Navigation Links
Vaccines in Medical Technology

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

... Pa., Aug. 7 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: ... to evaluate the influenza A(H1N1) 2009 monovalent vaccines using the same regulatory process by which it ... York (NYSE: SNY ). Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more ...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

... biotechnology company creating novel vaccines to address a broad range of infectious diseases ... produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing ... regulatory approval is needed before any vaccines can be sold in or outside the US; Novavax's pilot ...

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

... a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and ... Tumor Cells as Patient-Specific Anti-Tumor vaccines in Patients with Metastatic Melanoma," was ... the potential these types of personalized cancer vaccines have for patients diagnosed with metastatic ...

AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine

... over other influenza vaccine approaches in that vaccines can be rapidly constructed and tested, and are ... systems rather than eggs. In addition, our vaccines do not require the use of an adjuvant, and they ... scaling up the process used to manufacture VRP vaccines and anticipate yields up to 1 million doses of ...

Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet

... -- GSK Biologicals, GlaxoSmithKline's vaccines business, is one of the world's leading vaccine ... research, development and production with over 30 vaccines approved for marketing and 20 more in ... GSK Biologicals distributed 1.1 billion doses of vaccines to 176 countries in both the developed and the ...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

... biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human ... manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human ... issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to ...

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

... and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead ... products in development are recombinant subunit vaccines designed to protect against the lethal effects of ... significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and ...

CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

... in Philadelphia, PA. This data demonstrates that vaccines utilizing its L.E.A.P.S.(TM) (Ligand Epitope ... and colleagues showed that CEL-SCI's L.E.A.P.S. vaccines can activate and cause human immature dendritic ... These results were obtained for L.E.A.P.S. vaccines against HSV and HIV. The use of the L.E.A.P.S. ...

Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS

... products. Preclinical studies with different vaccines and the Phase I/II clinical study results using ... this strategy may be used for other injectable vaccines which are already approved or in development ... biotechnology company that develops novel vaccines for the prevention and treatment of infectious ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... rapid replication enables us to develop synthetic vaccines specifically tailored to destroy or restrict ... and markets novel forecasting tools and synthetic vaccines to fight virulent rapidly replicating diseases ... and HIV. The company's predictive products and vaccines in development are based upon the company's ...

Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine

... traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human ... biotechnology company focused on developing human vaccines for diseases caused by HIV-1 (Human ... issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

... meeting devoted exclusively to research on vaccines and related technologies for disease prevention ... W. Ripley Ballou, MD, deputy director of vaccines at the Bill & Melinda Gates Foundation, which ... accelerated efforts to deliver these and other vaccines to the world's poorest people. Under a ...

SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production

... the safe, cost effective manufacturing of viral vaccines and recombinant proteins for human and veterinary ... pharmaceutical industry for the manufacture of vaccines and proteins, and develops drugs for the ... portfolio of proprietary products in the area of vaccines and anti-viral molecules (hepatitis C). ...

Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin

... of this trial expands the spectrum of malaria vaccines in clinical development today," said Dr. ... is safe and effective." While most malaria vaccines in clinical development consist of recombinant or ... unique to the malaria vaccine field, such live vaccines are used for other diseases including smallpox, ...

Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine

... leading position in the development of vaccines against infectious diseases with significant ... Officer, Alexander von Gabain. Although vaccines against Streptococcus pneumoniae are available, ... known serotypes and it is essential to pursue new vaccines for distribution in countries with the highest ...

DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation

... and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead ... products in development are recombinant subunit vaccines designed to protect against the lethal effects of ... significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and ...

Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development

... Nobilon's commitment to bringing innovative vaccines for human health to the market using ... Inactivated, parenterally administered influenza vaccines have been available since the mid-1940s and ... Nevertheless, current inactivated influenza vaccines have limitations and are underutilized. ...

GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA

... traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human ... other vaccine candidates. GeoVax's DNA and MVA vaccines are used in a prime-boost protocol in which ... initiating human clinical trials testing its vaccines as potential therapies for people who are already ...

Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate

... Development of the Next Generation of Influenza vaccines with Broad Protection Against Multiple Strains ... biotechnology company, creating novel vaccines to address a broad range of infectious diseases ... produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing ...

Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference

... on Evaluation of Pandemic Influenza Prototype vaccines in Clinical Trials, Novavax, Inc. (Nasdaq: NVAX ... older, a population in which currently licensed vaccines have only modest efficacy. While current seasonal vaccines consist almost entirely of HA, similar to the ...

Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate

... may be differentiated from other influenza vaccines in several ways. First, it includes three viral ... matrix protein, M1. In contrast, most seasonal vaccines consist almost entirely of HA with little or no ... stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases ...

AFFiRiS Begins Development of a Parkinson's Vaccine

... Our AFFITOME technology enables us to develop vaccines that induce antibody specifically targeting ... has already succeeded in developing two vaccines and a hemodialysis program for the treatment of ... be responsible for Alzheimer's. Both Alzheimer's vaccines are currently being trialled on Alzheimer ...

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... (R)-formulated H5N1 pandemic influenza DNA vaccines induced T-cell responses against a matching ... trial. The company previously reported that the vaccines had achieved potentially protective levels of ... manufacturing program, this week at the DNA vaccines 2008 Conference (Las Vegas - December 9-11). ...

Epidemics of Both Type 1 Diabetes (Insulin Dependent) and Type 2 Diabetes (Obesity Related) Are Linked to Immunization

... immunization. Classen previously published proof vaccines are causing an epidemic of type 1 diabetes in ... syndrome in children are linked. Exposure to vaccines causes some individuals to develop an autoimmune ... "The picture is becoming clear. Not only are vaccines causing an epidemic of autoimmunity including ...

SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial

... exhibiting any symptoms. About DNA vaccines DNA vaccines may offer both technical and economic advantages compared with conventional vaccine approaches. DNA vaccines encode certain proteins associated with a target ...

Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa

... show that our investments in developing malaria vaccines are beginning to pay dividends," said Christian ... for children in Africa. History has shown that vaccines are the most powerful tool to control and ... "The vaccine works alongside standard infant vaccines of WHO's Expanded Program of Immunization (EPI), ...

Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate

... rights to develop and commercialize Paramyxovirus vaccines incorporating certain Virus-Like-Particles (VLPs) ... stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases ... produces these VLP based, potent, recombinant vaccines utilizing new, and efficient manufacturing ...

The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness

... The old, conventional smallpox vaccines which have been stockpiled around the world are ... may cause severe side effects, even death. These vaccines cannot be given to people who are immune ... company developing and producing novel vaccines for the treatment and prevention ...

GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America

... biotechnology company developing human vaccines for diseases caused by HIV-1 (Human ... Accordingly, HVTN's pharmacy will release the vaccines to each designated institution as directed by ... HIV-1 MVA (Modified Vaccinia Virus) boost. Both vaccines express the three major proteins of the AIDS ...

Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families 'Let's Fight Flu Together!'

... Mass., Nov. 10 /PRNewswire/ -- Novartis vaccines announced today a national public health ... influenza vaccination recommendations, Novartis vaccines has partnered with PTA (Parent Teacher ... vaccination clinics will help bring influenza vaccines to as many families as possible, which we hope ...

Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months

... in DNA- and protein-based infectious disease vaccines and peptide-based cancer vaccines. Alain P. ... H5N1 pandemic influenza DNA vaccines achieved potentially protective levels ... alternatives to conventional vaccines. DNA vaccines are fundamentally different ...

NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting

... CGI this year, Novavax is working to create novel vaccines and manufacturing solutions for producing avian and seasonal influenza vaccines with portable equipment that can be deployed ... infectious diseases each year by creating novel vaccines that can be produced in a cost effective and ...

Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients

... Therapeutic Cancer Vaccines Therapeutic cancer vaccines represent an emerging, experimental type ... disease. Researchers believe therapeutic cancer vaccines may help inhibit the progression of existing ... in New York (NYSE: SNY ). Sanofi pasteur, the vaccines division of sanofi-aventis Group, provided more ...

Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

... are required that can deliver safe and effective vaccines quickly and reliably," said Robert B. Belshe, ... a population in which currently licensed vaccines have only modest efficacy. Novavax has developed ... influenza strains. While current seasonal vaccines consist almost entirely of HA, the Novavax VLP ...

Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

... We believe that continued development of HIV vaccines remains among the world's top healthcare ... regimen using three doses of unadjuvanted DNA vaccines over a three-month period followed by a single ... the development. About the Vaccine The SMI/KI vaccines contain synthetic versions of genes ...

Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

... We believe that continued development of HIV vaccines remains among the world's top healthcare ... regimen using three doses of unadjuvanted DNA vaccines over a three-month period followed by a single ... About the Vaccine The SMI/Karolinska vaccines contain synthetic versions of genes encoding ...

MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research

... and commercialization rights to multiple vaccines against recurrent cancer for six different types ... to conduct Phase II trials with the licensed vaccines in ovarian and breast cancer. Pending successful ... exclusive rights to the use of the licensed vaccines and lymphocytes from successfully ...

Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US

... Aug. 1 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, began ... vaccine formulation were confirmed by the FDA's vaccines and Related Biological Products Advisory ... in February. Unlike other routinely recommended vaccines whose formulation remains constant over time, ...

Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data

... clinical trial data demonstrating that DNA vaccines can safely achieve significant immune responses ... fundamentally different from conventional vaccines because they do not contain any part of the virus ... pandemic influenza DNA vaccines demonstrated for the first time ...

Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC

... Listeria monocytogenes ("Lm") cancer vaccines based on technology developed by Dr. Yvonne ... Board. Advaxis is developing therapeutic cancer vaccines that enhance the immune system's cancer fighting ... such as cervical and head and neck. Current Lm vaccines in development target prostate, breast, ovarian ...
Other Contents
(Date:8/28/2014)... This news release is available in German . ... fresh water fish, owes its name to a striking pattern ... cell types, black cells, reflective silvery cells, and yellow cells ... fish and arrange as a multilayered mosaic to compose the ... all three cell types have to interact to form proper ...
(Date:8/28/2014)... MARC (Maximizing Access to Research Careers) Program has ... Society of America,s 27th Annual Mouse Molecular Genetics ... in Pacific Grove, California. These awards are ... doctorates and scientists from underrepresented groups into the ... encourage the participation of young scientists at the ...
(Date:8/28/2014)... MARC (Maximizing Access to Research Careers) Program has ... College of Sports Medicine,s Conference on Integrative Physiology ... Florida. These awards are meant to promote ... from underrepresented groups into the mainstream of the ... of young scientists at the American College of ...
Breaking Biology News(10 mins):How the zebrafish gets its stripes 2How the zebrafish gets its stripes 3
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 "I have ... neck surgeries, as well as many other surgeries in my ... from Richmond, Texas. "During my stays, I was unable to ... many other ailments. Two nurses freely had to physically rotate ... on either side of me and pulled the sheets. This ...
(Date:8/29/2014)... Gwyneth Paltrow, Beyonce and Angelina Jolie are only among ... all over the United States, to find the best fat ... quickly shed excess fat. And, recent inspiration has come from ... gluten products, eggs and meats for ingredients like goji berries ... this type of diet, one must be a celebrity to ...
(Date:8/29/2014)... August 29, 2014 Hep-Lock IV lines ... can be difficult to keep in place comfortably. "I ... infiltration and discomfort caused by medical tape," said an ... way to secure hep-lock IV lines." , The patent-pending ... medical tape, which avoids irritated skin and allergic reactions. ...
(Date:8/29/2014)... Spain Saturday 30 August 2014: The ACCA Clinical ... the App Store and Google Play. , When ... can make the difference and instant access to ... the Acute Cardiovascular Care Association (ACCA) of the ... allowing professionals to have immediate access to diagnostics ...
(Date:8/29/2014)... 2014 When subjected to validation using ... to be one of the most consistent instruments for ... the Hartman Personality Profile, and the “Big 5” are ... Each of these testing tools uses a short questionnaire ... personality type has been identified, the test results can ...
Breaking Medicine News(10 mins):Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 3Health News:Mobile app on emergency cardiac care aids best decisions in seconds 2Health News:Mobile app on emergency cardiac care aids best decisions in seconds 3Health News:DISC Personality Tests Demonstrate High Rates of “Test-Retest Reliability” 2Health News:DISC Personality Tests Demonstrate High Rates of “Test-Retest Reliability” 3
Other TagsOther Tags